Skip to content

Capturing the $175 Billion Opportunity in Clinical Laboratory Services

From Routine Testing to Precision Diagnostics: What’s Reshaping the Industry Today
Instant Access

Download the Full Analysis

Clinical laboratory services are shifting from fragmented, volume-led operations toward more integrated and efficiency-driven models as reimbursement pressure intensifies, automation expands, and demand for specialized diagnostics increases. This is reshaping how laboratories scale, structure workflows, and manage costs.

Our latest analysis shows how hospital-affiliated and mid-tier laboratories are responding to Protecting Access to Medicare Act (PAMA) pricing pressure, payer utilization controls, and rising operating costs by streamlining test menus, improving workflow efficiency, and strengthening operational scalability.

Is your laboratory strategy built for a value-driven ecosystem, or are outdated operating models limiting your revenue pipelines?

What This Analysis Reveals for Clinical Lab Executives:

Strategies to address growth barriers including regulatory compliance burdens, medical technologist shortages, and rising capital investment pressures.
Emerging opportunities across oncology testing, home-based diagnostics, and AI-driven digital pathology driving the next wave of market value.
Competitive analysis of providers like Labcorp, Quest Diagnostics, and Sonic Healthcare USA across routine testing scale and high-value diagnostics.

Discover the competitive dynamics, growth drivers, and strategic opportunities redefining the future of US clinical laboratory services.